protacxn,geneid,genesymbol,cid,drugtype,drugname,druggroup,drugaction,drugdetail,targettype,targetid,targetname,targetcomponent,targetcomponentname,generalfunc,specificfunc,pmids,cmpdname,dois
   P30556,185,AGTR1,3961,small molecule,Losartan,approved,antagonist,DB00678,target,BE0000062,Type-1 angiotensin II receptor,P30556,Type-1 angiotensin II receptor,Protein heterodimerization activity,Receptor for angiotensin II. Mediates its action by association with G proteins that activate a phosphatidylinositol-calcium second messenger system.,11752352|15026875|15991937|12710529|12719755|15573751,Losartan,10.1093/nar/30.1.412|10.1177/000331970405500212|10.1517/13543784.7.11.1897|10.1139/y02-156|10.1113/eph8802476|
P11712,1559,CYP2C9,3961,small molecule,Losartan,approved,substrate,DB00678,enzyme,BE0002793,Cytochrome P450 2C9,P11712,Cytochrome P450 2C9,Steroid hydroxylase activity,"Cytochromes P450 are a group of heme-thiolate monooxygenases. In liver microsomes, this enzyme is involved in an NADPH-dependent electron transport pathway. It oxidizes a variety of structurally unrelated compounds, including steroids, fatty acids, and xenobiotics. This enzyme contributes to the wide pharmacokinetics variability of the metabolism of drugs such as S-warfarin, diclofenac, phenytoin, tolbutamide and losartan.",10678291|16029066|19515014|11823761,Losartan,10.1592/phco.20.3.130.34788|10.2165/00003088-200544080-00003|10.2174/092986709789057635|10.1067/mcp.2002.121216
P08684,1576,CYP3A4,3961,small molecule,Losartan,approved,substrate; inhibitor,DB00678,enzyme,BE0002638,Cytochrome P450 3A4,P08684,Cytochrome P450 3A4,Vitamin d3 25-hydroxylase activity,"Cytochromes P450 are a group of heme-thiolate monooxygenases. In liver microsomes, this enzyme is involved in an NADPH-dependent electron transport pathway. It performs a variety of oxidation reactions (e.g. caffeine 8-oxidation, omeprazole sulphoxidation, midazolam 1'-hydroxylation and midazolam 4-hydroxylation) of structurally unrelated compounds, including steroids, fatty acids, and xenobiotics. Acts as a 1,8-cineole 2-exo-monooxygenase. The enzyme also hydroxylates etoposide (PubMed:11159812). Catalyzes 4-beta-hydroxylation of cholesterol. May catalyze 25-hydroxylation of cholesterol in vitro (PubMed:21576599).",10678291|16029066|19515014|25424246,Losartan,10.1592/phco.20.3.130.34788|10.2165/00003088-200544080-00003|10.2174/092986709789057635|10.1111/bcpt.12355
P33261,1557,CYP2C19,3961,small molecule,Losartan,approved,inhibitor,DB00678,enzyme,BE0003536,Cytochrome P450 2C19,P33261,Cytochrome P450 2C19,Steroid hydroxylase activity,"Responsible for the metabolism of a number of therapeutic agents such as the anticonvulsant drug S-mephenytoin, omeprazole, proguanil, certain barbiturates, diazepam, propranolol, citalopram and imipramine.",10877007,Losartan,10.1007/s002280050731
P22309,54658,UGT1A1,3961,small molecule,Losartan,approved,substrate,DB00678,enzyme,BE0003541,UDP-glucuronosyltransferase 1-1,P22309,UDP-glucuronosyltransferase 1-1,Steroid binding,"UDPGT is of major importance in the conjugation and subsequent elimination of potentially toxic xenobiotics and endogenous compounds. This isoform glucuronidates bilirubin IX-alpha to form both the IX-alpha-C8 and IX-alpha-C12 monoconjugates and diconjugate. Is also able to catalyze the glucuronidation of 17beta-estradiol, 17alpha-ethinylestradiol, 1-hydroxypyrene, 4-methylumbelliferone, 1-naphthol, paranitrophenol, scopoletin, and umbelliferone. Isoform 2 lacks transferase activity but acts as a negative regulator of isoform 1.",19515014,Losartan,10.2174/092986709789057635
P35503,54659,UGT1A3,3961,small molecule,Losartan,approved,substrate,DB00678,enzyme,BE0003677,UDP-glucuronosyltransferase 1-3,P35503,UDP-glucuronosyltransferase 1-3,Retinoic acid binding,UDPGT is of major importance in the conjugation and subsequent elimination of potentially toxic xenobiotics and endogenous compounds. Isoform 2 lacks transferase activity but acts as a negative regulator of isoform 1.,19515014,Losartan,10.2174/092986709789057635
Q9HAW8,54575,UGT1A10,3961,small molecule,Losartan,approved,substrate,DB00678,enzyme,BE0003678,UDP-glucuronosyltransferase 1-10,Q9HAW8,UDP-glucuronosyltransferase 1-10,Protein kinase c binding,UDPGT is of major importance in the conjugation and subsequent elimination of potentially toxic xenobiotics and endogenous compounds. Isoform 2 lacks transferase activity but acts as a negative regulator of isoform 1.,19515014,Losartan,10.2174/092986709789057635
P16662,7364,UGT2B7,3961,small molecule,Losartan,approved,substrate,DB00678,enzyme,BE0003679,UDP-glucuronosyltransferase 2B7,P16662,UDP-glucuronosyltransferase 2B7,Glucuronosyltransferase activity,"UDPGT is of major importance in the conjugation and subsequent elimination of potentially toxic xenobiotics and endogenous compounds.Its unique specificity for 3,4-catechol estrogens and estriol suggests it may play an important role in regulating the level and activity of these potent and active estrogen metabolites. Is also active with androsterone, hyodeoxycholic acid and tetrachlorocatechol (in vitro).",19515014,Losartan,10.2174/092986709789057635
O75795,7367,UGT2B17,3961,small molecule,Losartan,approved,substrate,DB00678,enzyme,BE0003680,UDP-glucuronosyltransferase 2B17,O75795,UDP-glucuronosyltransferase 2B17,Glucuronosyltransferase activity,"UDPGT is of major importance in the conjugation and subsequent elimination of potentially toxic xenobiotics and endogenous compounds. The major substrates of this isozyme are eugenol > 4-methylumbelliferone > dihydrotestosterone (DHT) > androstane-3-alpha,17-beta-diol (3-alpha-diol) > testosterone > androsterone (ADT).",19515014,Losartan,10.2174/092986709789057635
P10632,1558,CYP2C8,3961,small molecule,Losartan,approved,inhibitor,DB00678,enzyme,BE0002887,Cytochrome P450 2C8,P10632,Cytochrome P450 2C8,Steroid hydroxylase activity,"Cytochromes P450 are a group of heme-thiolate monooxygenases. In liver microsomes, this enzyme is involved in an NADPH-dependent electron transport pathway. It oxidizes a variety of structurally unrelated compounds, including steroids, fatty acids, and xenobiotics. In the epoxidation of arachidonic acid it generates only 14,15- and 11,12-cis-epoxyeicosatrienoic acids. It is the principal enzyme responsible for the metabolism the anti-cancer drug paclitaxel (taxol).",25424246,Losartan,10.1111/bcpt.12355
P08183,5243,ABCB1,3961,small molecule,Losartan,approved,substrate; inhibitor,DB00678,transporter,BE0001032,P-glycoprotein 1,P08183,Multidrug resistance protein 1,Xenobiotic-transporting atpase activity,Energy-dependent efflux pump responsible for decreased drug accumulation in multidrug-resistant cells.,11895100|8621716|10725273,Losartan,10.1016/s0024-3205(01)01494-1|10.1074/jbc.271.6.3163|10.1038/sj.bjp.0703150
Q4U2R8,9356,SLC22A6,3961,small molecule,Losartan,approved,inhibitor,DB00678,transporter,BE0001066,Solute carrier family 22 member 6,Q4U2R8,Solute carrier family 22 member 6,Sodium-independent organic anion transmembrane transporter activity,"Involved in the renal elimination of endogenous and exogenous organic anions. Functions as organic anion exchanger when the uptake of one molecule of organic anion is coupled with an efflux of one molecule of endogenous dicarboxylic acid (glutarate, ketoglutarate, etc). Mediates the sodium-independent uptake of 2,3-dimercapto-1-propanesulfonic acid (DMPS) (By similarity). Mediates the sodium-independent uptake of p-aminohippurate (PAH), ochratoxin (OTA), acyclovir (ACV), 3'-azido-3-'deoxythymidine (AZT), cimetidine (CMD), 2,4-dichloro-phenoxyacetate (2,4-D), hippurate (HA), indoleacetate (IA), indoxyl sulfate (IS) and 3-carboxy-4-methyl-5-propyl-2-furanpropionate (CMPF), cidofovir, adefovir, 9-(2-phosphonylmethoxyethyl) guanine (PMEG), 9-(2-phosphonylmethoxyethyl) diaminopurine (PMEDAP) and edaravone sulfate. PAH uptake is inhibited by p-chloromercuribenzenesulphonate (PCMBS), diethyl pyrocarbonate (DEPC), sulindac, diclofenac, carprofen, glutarate and okadaic acid (By similarity). PAH uptake is inhibited by benzothiazolylcysteine (BTC), S-chlorotrifluoroethylcysteine (CTFC), cysteine S-conjugates S-dichlorovinylcysteine (DCVC), furosemide, steviol, phorbol 12-myristate 13-acetate (PMA), calcium ionophore A23187, benzylpenicillin, furosemide, indomethacin, bumetamide, losartan, probenecid, phenol red, urate, and alpha-ketoglutarate.",10049739,Losartan,10.1006/bbrc.1998.9978
Q96S37,116085,SLC22A12,3961,small molecule,Losartan,approved,inhibitor,DB00678,transporter,BE0004782,Solute carrier family 22 member 12,Q96S37,Solute carrier family 22 member 12,Urate transmembrane transporter activity,Required for efficient urate re-absorption in the kidney. Regulates blood urate levels. Mediates saturable urate uptake by facilitating the exchange of urate against organic anions.,22359229|8743498,Losartan,10.1007/s11926-012-0240-z|10.1038/ki.1996.268
Q9NRM0,56606,SLC2A9,3961,small molecule,Losartan,approved,inhibitor,DB00678,transporter,BE0004783,"Solute carrier family 2, facilitated glucose transporter member 9",Q9NRM0,"Solute carrier family 2, facilitated glucose transporter member 9",Sugar:proton symporter activity,Transport urate and fructose. May have a role in the urate reabsorption by proximal tubules. Also transports glucose at low rate.,22359229|8743498,Losartan,10.1007/s11926-012-0240-z|10.1038/ki.1996.268
O95342,8647,ABCB11,3961,small molecule,Losartan,approved,substrate,DB00678,transporter,BE0000703,Bile salt export pump,O95342,Bile salt export pump,Transporter activity,Involved in the ATP-dependent secretion of bile salts into the canaliculus of hepatocytes.,24014644,Losartan,10.1093/toxsci/kft197
P02768,213,ALB,3961,small molecule,Losartan,approved,substrate,DB00678,carrier,BE0000530,Serum albumin,P02768,Serum albumin,Toxic substance binding,"Serum albumin, the main protein of plasma, has a good binding capacity for water, Ca(2+), Na(+), K(+), fatty acids, hormones, bilirubin and drugs. Its main function is the regulation of the colloidal osmotic pressure of blood. Major zinc transporter in plasma, typically binds about 80% of all plasma zinc.",16029066,Losartan,10.2165/00003088-200544080-00003
